Literature DB >> 6575852

Characterization and partial purification of 'renocortins': two polypeptides formed in renal cells causing the anti-phospholipase-like action of glucocorticoids.

J F Cloix, O Colard, B Rothhut, F Russo-Marie.   

Abstract

1 Anti-inflammatory steroids reduce prostaglandin E2 (PGE2) synthesis in rat renomedullary interstitial cells in culture by inhibiting the release of arachidonic acid from membranous phospholipid stores, exhibiting antiphospholipase-like properties. 2 After treatment of the cells with dexamethasone 10(-6)M, these cells release a protein in the supernatant. 3 This supernatant is able to inhibit PGE2 secretion in untreated cells and to inhibit phospholipase A2 activity in an in vitro system. 4 Using chromatofocusing separation, we showed that two distinct proteins exist with isoelectric points of 5.8 and 8.3. 5 Using gel permeation separation, we showed that two proteins exist with apparent molecular weights of 15,000 and 30,000 daltons. 6 We conclude that, in renal cells in culture, anti-inflammatory steroids induce the synthesis and the release of two polypeptides which we have named 'Renocortins' (induced by corticoids in renal cells) causing the antiphospholipase-like action of glucocorticoids. 7 Our results are in good agreement with others, but as renal cells are not directly involved in the inflammatory process, we suggest that this steroid-induced phenomenon is not solely involved in the inflammatory reaction but is of more general physiological relevance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6575852      PMCID: PMC2044833          DOI: 10.1111/j.1476-5381.1983.tb10526.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Corticosteroids inhibit prostaglandin production by rheumatiod synovia.

Authors:  F Kantrowitz; D R Robinson; M B McGuire; L Levine
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

2.  Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells.

Authors:  A H Tashjian; E F Voelkel; J McDonough; L Levine
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

3.  Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture.

Authors:  E E Muirhead; G Germain; B E Leach; J A Pitcock; P Stephenson; B Brooks; W L Brosius; E G Daniels; J W Hinman
Journal:  Circ Res       Date:  1972-09       Impact factor: 17.367

4.  Fatty acid and prostaglandin composition of left ventricular myocardium from dexamethasone-treated dogs with severe low output syndrome (LOS).

Authors:  C A Bonilla; J Dupont
Journal:  Prostaglandins       Date:  1976-06

5.  Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig.

Authors:  R J Gryglewski; B Panczenko; R Korbut; L Grodzinska; A Ocetkiewicz
Journal:  Prostaglandins       Date:  1975-08

6.  Mechanism of steroid action in inflammation: inhibition of prostaglandin synthesis and release.

Authors:  Y Floman; U Zor
Journal:  Prostaglandins       Date:  1976-09

7.  Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids.

Authors:  F P Nijkamp; R J Flower; S Moncada; J R Vane
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

8.  Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts.

Authors:  D S Newcombe; J V Fahey; Y Ishikawa
Journal:  Prostaglandins       Date:  1977-02

9.  Endogenous inhibitor of prostaglandin synthetase.

Authors:  S A Saeed; W J McDonald-Gibson; J Cuthbert; J L Copas; C Schneider; P J Gardiner; N M Butt; H O Collier
Journal:  Nature       Date:  1977-11-03       Impact factor: 49.962

10.  Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids.

Authors:  S L Hong; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

View more
  28 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

3.  Enhanced expression of lipocortin-1 as a new immunosuppressive protein in cancer patients and its influence on reduced in vitro peripheral blood lymphocyte response to mitogens.

Authors:  H Koseki; K Shiiba; Y Suzuki; T Asanuma; S Matsuno
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.

Authors:  J Carlstedt-Duke; M Brönnegård; B Strandvik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Multiple control of inflammation by glucocorticoids.

Authors:  M Di Rosa; A Calignano; R Carnuccio; A Ialenti; L Sautebin
Journal:  Agents Actions       Date:  1986-01

6.  Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells.

Authors:  E Moilanen
Journal:  Agents Actions       Date:  1989-03

7.  Glucocorticoids in myocardial and cerebral infarction.

Authors:  M Koltai; A Tósaki; I Leprán; L Szekeres
Journal:  Agents Actions       Date:  1986-01

8.  Background and discovery of lipocortins.

Authors:  R J Flower
Journal:  Agents Actions       Date:  1986-01

9.  Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein.

Authors:  R Carnuccio; M Di Rosa; B Guerrasio; T Iuvone; L Sautebin
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

10.  The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action.

Authors:  J Vane
Journal:  Drugs       Date:  1987       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.